Mohbad’s Family Conducts Fresh Autopsy, Awaits Results
Another toxicology test to ascertain the cause of the death of the late Nigerian singer, Ilerioluwa Oladimeji Aloba aka Mohbad has been conducted by the family.
Recall, Mohbad died under mysterious circumstances on September 12, 2023, and his body was buried the next day.
After several agitations from Nigerians who queried why he was buried in a rush, his body was exhumed on September 21, and an autopsy was performed.
In May, Wahab Shittu, a Senior Advocate of Nigeria (SAN), stated that the pathologist in charge of the autopsy informed the coroner that Mohbad’s body had decomposed by the time the test was conducted, making it impossible to ascertain the cause of death.
Following this, the Aloba family, last month rejected the autopsy result and demanded an independent post-mortem and toxicology test.
A member of the Aloba family’s legal team, Monisola Odumosu on Tuesday, however, announced in a statement that a two-part autopsy is being conducted on Mohbad.
Odumosu disclosed that the first phase of the autopsy had been carried out last week, while the second phase involves a toxicology and histology test. She stated that the procedure was witnessed by Joseph Aloba, Mohbad’s father, and a pathologist representing Wunmi, the late singer’s wife.
“The second autopsy, as requested by the Aloba family and ordered by the Magistrate of the Coroner Court, Ms. T.A. Shotobi, was conducted on Friday, July 19, and Saturday, July 20, 2024. This autopsy is a two-part exercise, with the first part now completed.
“If the cause of death cannot be determined from this initial examination, the second part will proceed, involving a toxicology and histology test on the necessary samples already obtained.
“This comprehensive procedure, conducted last Friday, was witnessed only by Mr. Joseph Aloba, the forensic pathologist appointed by Mr. Joseph Aloba and his team, legal representatives of both Mr. Joseph Aloba and a pathologist appointed by Wunmi Aloba to observe the procedure.” It read.
Follow us for more.
Author
